Search Results 421-430 of 17261 for Break STD Taboo

  1. Epicardial Delivery Of XC001 Gene Therapy To Promote Angiogenesis In CAD Patients Undergoing Treatment With CABG - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  2. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  3. Clinical trials - Gastroenterology and Hepatology

    ... standard of care chemotherapy in participants with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). Cohort of Patients With Fatty ...

  4. Obstetrics and Gynecology - Clinical trials

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  5. General Internal Medicine - Clinical trials

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  6. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  7. Phase 2/3 Study Of KPL-387 In Recurrent Pericarditis - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  8. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  9. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

    ... standard therapy. ... standard therapy containing an HMA or a standard cytarabine-containing induction therapy ... break or leak. Exclusion Criteria: Disease- ...

  10. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...